Yeah DSA, ffs this is a gross oversimplification and factually incorrect about the commercialisation timeline and requirements. Sonic failed to deliver, so they pivoted.. you can't just commercialise one test in the US without a having a certified lab, reimbursement codes, proper processes ect ect.... typically takes 18 to 36 months post validation so attributing PIQs share price solely to not picking one test, or galloping to the next partnership that potentially wasn't even there, is just factually wrong. This is a textbook timeline for diagnostics commercialisation, of course amazing best case acceleration would be better, but shit rarely is. Which is why its hard to listen to this dribble constantly...you're here, you like the stock, stop obsessing about Richard... it's a little weird at this point tbh.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)